These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18719907)

  • 41. MicroPET imaging of gene transfer with a somatostatin receptor-based reporter gene and (94m)Tc-Demotate 1.
    Rogers BE; Parry JJ; Andrews R; Cordopatis P; Nock BA; Maina T
    J Nucl Med; 2005 Nov; 46(11):1889-97. PubMed ID: 16269604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
    Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
    Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity.
    Hodge JW; McLaughlin JP; Abrams SI; Shupert WL; Schlom J; Kantor JA
    Cancer Res; 1995 Aug; 55(16):3598-603. PubMed ID: 7543017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA vaccine expressing repeated carcinoembryonic antigen (CEA)(625-667) induces strong immunity in mice.
    Li D; Hua S; Fan Y; Xu S; Duan X; Liu L; Che Y; Li S; Tan Y
    Immunol Lett; 2011 Mar; 135(1-2):124-8. PubMed ID: 21073899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.
    Krebs S; Ahad A; Carter LM; Eyquem J; Brand C; Bell M; Ponomarev V; Reiner T; Meares CF; Gottschalk S; Sadelain M; Larson SM; Weber WA
    J Nucl Med; 2018 Dec; 59(12):1894-1900. PubMed ID: 29903928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer.
    Chester KA; Mayer A; Bhatia J; Robson L; Spencer DI; Cooke SP; Flynn AA; Sharma SK; Boxer G; Pedley RB; Begent RH
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S8-12. PubMed ID: 10950140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In Vivo Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell-Mediated Tumor Killing.
    Lehmann S; Perera R; Grimm HP; Sam J; Colombetti S; Fauti T; Fahrni L; Schaller T; Freimoser-Grundschober A; Zielonka J; Stoma S; Rudin M; Klein C; Umana P; Gerdes C; Bacac M
    Clin Cancer Res; 2016 Sep; 22(17):4417-27. PubMed ID: 27117182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
    Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
    J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immuno-PET Imaging and Pharmacokinetics of an Anti-CEA scFv-based Trimerbody and Its Monomeric Counterpart in Human Gastric Carcinoma-Bearing Mice.
    Rios X; Compte M; Gómez-Vallejo V; Cossío U; Baz Z; Morcillo MÁ; Ramos-Cabrer P; Alvarez-Vallina L; Llop J
    Mol Pharm; 2019 Mar; 16(3):1025-1035. PubMed ID: 30726099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
    Pietersz GA; Patrick MR; Chester KA
    J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective expression of carcinoembryonic antigen promoter in cancer cell lines: targeting strategy for gene therapy in colorectal cancer.
    Fichera A; Michelassi F; Arenas RB
    Dis Colon Rectum; 1998 Jun; 41(6):747-54. PubMed ID: 9645743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen.
    Ayala M; Dueñas M; Santos A; Vázquez J; Menéndez A; Silva A; Gavilondo JV
    Biotechniques; 1992 Nov; 13(5):790-9. PubMed ID: 1418981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production of carcinoembryonic antigen (CEA) N-A3 domain in Pichia pastoris by fermentation.
    Hellwig S; Robin F; Drossard J; Raven NP; Vaquero-Martin C; Shively JE; Fischer R
    Biotechnol Appl Biochem; 1999 Dec; 30(3):267-75. PubMed ID: 10574697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel CEA vaccine stimulates T cell proliferation, gammaIFN secretion and CEA specific CTL responses.
    Parsons T; Spendlove I; Nirula R; Writer M; Carter G; Carr F; Durrant LG
    Vaccine; 2004 Sep; 22(25-26):3487-94. PubMed ID: 15308376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment.
    Girgis MD; Olafsen T; Kenanova V; McCabe KE; Wu AM; Tomlinson JS
    EJNMMI Res; 2011 Nov; 1(1):24. PubMed ID: 22214289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and as rejection antigen in syngeneic rats.
    Pèlegrin A; Terskikh A; Hayoz D; Chalandon Y; Olsson NO; Folli S; Buchegger F; Kromer B; Schwarz K; Martin M
    Int J Cancer; 1992 Aug; 52(1):110-9. PubMed ID: 1500216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Production, purification and characterization of an anti-(carcinoembryonic antigen) recombinant single-chain Fv antibody fragment.
    Pérez L; Vázquez JE; Ayala M; Siccardi AG; Tresoldi E; de Lalla C; Gavilondo JV; Sidoli A
    Biotechnol Appl Biochem; 1996 Aug; 24(1):79-82. PubMed ID: 8756397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy.
    Clarke P; Mann J; Simpson JF; Rickard-Dickson K; Primus FJ
    Cancer Res; 1998 Apr; 58(7):1469-77. PubMed ID: 9537250
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Mowday AM; Copp JN; Syddall SP; Dubois LJ; Wang J; Lieuwes NG; Biemans R; Ashoorzadeh A; Abbattista MR; Williams EM; Guise CP; Lambin P; Ackerley DF; Smaill JB; Theys J; Patterson AV
    Theranostics; 2020; 10(23):10548-10562. PubMed ID: 32929365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA.
    Hombach A; Koch D; Sircar R; Heuser C; Diehl V; Kruis W; Pohl C; Abken H
    Gene Ther; 1999 Feb; 6(2):300-4. PubMed ID: 10435115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.